2012年7月29日星期日
's first trademark case due to the trademark value exceeding
's first trademark case due to the trademark value exceeding one hundred billion yuan. China International Economic and Trade Arbitration Commission has made a ruling in favor of Guangzhou Pharmaceutical, David Tao Group, a subsidiary of JDB to stop using "Wong Lo Kat" trademark. Shortly afterwards, JDB has announced that the original red pot "Wong Lo Kat herbal tea changed its name to the JDB herbal tea, and to showcase the new packaging of the red cans to remove the word" Wong Lo Kat ". Guangzhou Pharmaceutical said, Guangzhou Pharmaceutical to recover the red cans with red bottle "Wong Lo Kat" herbal tea's production business the right enterprise malicious external spread "red tank Wong Lo Kat changed its name to" the false information, this "Wong Lo Kat" brand caused a serious damage. and deliberately distorted the history of "Wong Lo Kat" brand. Guangzhou Pharmaceutical, defamatory, any red tank Wanglaoji will pay serious attention to, and reserves the right to take legal action to pursue tort liability. Currently on the market, referred to as Guangzhou Pharmaceutical, still red pot with red bottle "Wong Lo Kat herbal tea in the sale. The reporter found a number of supermarkets in Guangzhou, many of the "Wong Lo Kat herbal tea is signed" JDB "factory. Guangzhou Pharmaceutical without wide drug authorization, the above products are infringing goods, any enterprise or individual to be the sale would constitute trademark infringement. Ni, Group Deputy General Manager of Guangzhou Pharmaceutical in accordance with the East had also shall be investigated, and eliminate confusion in the market, "Wong Lo Kat" trademark. Guangzhou Pharmaceutical, said in a statement, without a license, any enterprise shall be entitled to the dissemination of any Wong Lo Kat "," red tank Wanglaoji "," Red Bottle Wanglaoji "product management information and business advertising, no qualifications spread red tank Wanglaoji changed its name to "false
information.
订阅:
博文评论 (Atom)
没有评论:
发表评论